Document is current

Article History

Received: 5 March 2025

Accepted: 20 November 2025

First Online: 2 December 2025

Declaration

:

: All participants provided written informed consents for their participation in the study and agreed to provide their contact information and to be called at certain times. The study was approved by the Clinical Researches Ethics Committee of Ankara University Faculty of Medicine (dated: 06 June 2022, approval no: 12.540.22) and was conducted in accordance with the Declaration of Helsinki.

: Not applicable.

: The study was presented as a poster presentation at the 60th ERA Congress which was held on June 15–18, 2023 in Milan, Italy.

: MA, KA, BT, SS, EAB, MSU, OG, SK, and BA have received funding support for the present manuscript from Turkish Society of Nephrology and partly from Novo Nordisk. MA has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Menarini, Novo Nordisk, Recordati, Sandoz, and Sanofi and has participated on a Data Safety Monitoring Board or Advisory Board for Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Novo Nordisk. KA has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Baxter, Amgen, AstraZeneca, and Astellas and has received support for attending meetings and/or travel from Baxter, Amgen, Nobel. BT has received consulting fees from Chiesi, payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Sanofi, Takeda, Amgen, Baxter, Novartis, AstraZeneca, Astellas, Nobel, Menarini, Fresenius Medical Care, Bayer, and Abdi İbrahim, and support for attending meetings and/or travel from Bayer, Sanofi, Takeda, Baxter, Amgen, and Chinook, and participated on a Data Safety Monitoring Board or Advisory Board for Sanofi. SS has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Bayer, Boehringer Ingelheim, AstraZeneca, Amgen, GlaxoSmithKline and support for attending meetings and/or travel from Bayer, Boehringer Ingelheim, AstraZeneca, Amgen. EAB has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Amgen, AstraZeneca, Boehringer Ingelheim, Bayer and support for attending meetings and/or travel from Amgen, AstraZeneca, Bayer. MSU has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Bayer, Boehringer Ingelheim, AstraZeneca, Amgen, GlaxoSmithKline and support for attending meetings and/or travel from Bayer, Boehringer Ingelheim, AstraZeneca, Amgen. BA has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Bayer, Boehringer Ingelheim, AstraZeneca, Amgen, GlaxoSmithKline and support for attending meetings and/or travel from Bayer, Boehringer Ingelheim, AstraZeneca, Amgen. All the remaining authors- AY, ARO, HZT, NS -declare that they have no competing interests.